Beruflich Dokumente
Kultur Dokumente
units/mL).
Dilute drug volumes in 30 mL water prior to ingestion
Administer doses every 15 minutes
Doses 1-2: Take 1 mL of 4 mg/ml solution and add to 63 mL sterile water for
irrigation to obtain a 0.0625 mg/ml (100 units/mL); Withdraw appropriate
volumes to make doses.
Doses 3-6: Take 2 mL of 4 mg/ml solution and add to 30 mL sterile water for
irrigation to obtain a 0.25 mg/ml (400 units/mL). Withdraw appropriate volumes
to make doses.
Doses 7-9: Withdraw appropriate volumes from 4 mg/ml solution to make
doses 7-9.
Doses 10-14: Withdraw appropriate volumes from the stock solution (50 mg/ml
or 80,000 units/mL) solution to make doses 10-14.
This is a confidential professional/peer review and quality assessment document of Marquette General Health System of Marquette, MI. It is protected from disclosure pursuant to the
provisions of MCL 333.20175, MCL 333.21513, MCL 21515, MCL 331.531, MCL 331.533, MCL 330.1143a, and other state and federal laws. Unauthorized disclosure or duplication is
absolutely prohibited.
Cumulative
Dose (mg)
0.015
0.045
0.105
0.23
0.48
1
2
4
8
15
30
60
123
250
500
1000
2000
This is a confidential professional/peer review and quality assessment document of Marquette General Health System of Marquette, MI. It is protected from disclosure pursuant to the
provisions of MCL 333.20175, MCL 333.21513, MCL 21515, MCL 331.531, MCL 331.533, MCL 330.1143a, and other state and federal laws. Unauthorized disclosure or duplication is
absolutely prohibited.
Cumulative
Dose (mg)
0.8/0.16
8.8/1.76
48.8/9.76
128.9/92
528.9/172
1208.9/308
2408/548
Preparation
Dilute 30 ml of SMX/TMP (80 mg/16mg per ml) injection in 600 ml of diluent to
obtain a concentration of 4mg/0.8 mg per ml. Administer each dose over 15
minutes.** The IV line should be flushed following each dose to ensure
complete delivery of medication.
*Further dilute the first dose to 10 ml for ease of administration.
**This protocol requires an infusion pump for administration. The interval
between doses is 20 minutes. Following final dose, therapeutic doses of
SMX/TMP may be scheduled at normal intervals.
This is a confidential professional/peer review and quality assessment document of Marquette General Health System of Marquette, MI. It is protected from disclosure pursuant to the
provisions of MCL 333.20175, MCL 333.21513, MCL 21515, MCL 331.531, MCL 331.533, MCL 330.1143a, and other state and federal laws. Unauthorized disclosure or duplication is
absolutely prohibited.
Infusion
Rate
(mg/min)
Dose/
30 min
Cumulative
Dose (mg)
0.0001
0.003
0.003
0.0001
0.0002
0.006
0.009
0.001
0.001
0.03
0.039
0.001
0.002
0.06
0.099
0.01
0.01
0.3
0.399
150
0.01
0.02
0.6
0.999
180
0.1
0.1
3.999
190
0.1
0.2
9.999
200
0.1
0.3
18.999
210
60
69.999
240
10
120
189.999
Time
(min)
Dose
#
Bag
#
0.0001
30
60
90
120
250
11
5
2
3
6
180*
500
Developed from similar protocols in Ann Pharmacother. 2003 Apr;37:513-6. &
Allergy. 1997;52:683-4.
Dose
(mg)
Preparation
1. Bag #5 is prepared first. Remove the overfill from a 250 ml bag of 0.9% sodium chloride
(NS) and add 500 mg of imipenem to obtain a 2 mg/ml concentration. Label Bag #5 (2
mg/ml).
2. Bag#4: Remove 10 ml of the 2 mg/ml solution from Bag#5 and add it to 200 ml of NS.
Label Bag #4 (0.1 mg/ml)
3. Bag#3: Remove 10 ml of the 0.1 mg/ml solution from Bag#4 and add it to 100 ml of NS.
Label Bag #3 (0.01 mg/ml).
4. Bag#2: Remove 10 ml of the 0.01 mg/ml solution from Bag#3 and add it to 100 ml of NS.
Label Bag #2 (0.001 mg/ml).
5. Bag#1: Remove 10 ml of the 0.001 mg/ml solution from Bag#2 and add it to 100 ml of
NS. Label Bag #1 (0.0001 mg/ml).
Administration
Bags #1 - #3 (doses #1-6) are administered over a one hour period. The rate of each bag
should be doubled after 30 minutes.
Bag #4 (doses7-9) is administered over 1.5 hours. The rate of infusion should increase
every 30 minutes.
Bag #5 (doses 9-11) is administered over ~2 hours. The rate of infusion is increased every
30 minutes.
*Dose #11 should infuse until the bag is empty to obtain a cumulative dose of 500 mg.
Following successful desensitization, standard doses of imipenem may be administered at
the normal interval.
This is a confidential professional/peer review and quality assessment document of Marquette General Health System of Marquette, MI. It is protected from disclosure pursuant to the
provisions of MCL 333.20175, MCL 333.21513, MCL 21515, MCL 331.531, MCL 331.533, MCL 330.1143a, and other state and federal laws. Unauthorized disclosure or duplication is
absolutely prohibited.
Dose #
Infusion Directions
Initiate infusion at 0.5 ml/min (30 ml/hour) and increase by 0.5 ml/min (30
ml/hour) as tolerated every 5 minutes to a maximum rate of 5 ml/min (300
ml/hour). If pruritus, hypotension, rash, or difficulty breathing occurs, stop
infusion and reinfuse the previously tolerated infusion at the highest
tolerated rate. This step may be repeated up to three times for any given
concentration.
Upon completion of infusion #5, immediately administer the required dose
of vancomycin in the usual dilution of NS or D5W over 2 hours. Decrease
the rate if the patient becomes symptomatic or, alternatively, increase the
rate if the patient tolerates the dose. Administer diphenhydramine 50 mg
by mouth 1 hour prior to each standard dose.
This is a confidential professional/peer review and quality assessment document of Marquette General Health System of Marquette, MI. It is protected from disclosure pursuant to the
provisions of MCL 333.20175, MCL 333.21513, MCL 21515, MCL 331.531, MCL 331.533, MCL 330.1143a, and other state and federal laws. Unauthorized disclosure or duplication is
absolutely prohibited.
Cumulative
(Dose)
0.001
0.003
0.007
0.015
0.031
0.063
0.127
0.255
0.511
1.023
2.023
4.023
8.023
16.023
32.023
64.023
80.023
This is a confidential professional/peer review and quality assessment document of Marquette General Health System of Marquette, MI. It is protected from disclosure pursuant to the
provisions of MCL 333.20175, MCL 333.21513, MCL 21515, MCL 331.531, MCL 331.533, MCL 330.1143a, and other state and federal laws. Unauthorized disclosure or duplication is
absolutely prohibited.
Meropenem
Concentration
(mg)
0.004
0.02
0.1
0.6
3
15
30
62
125
10
250
11
500
12
1000
Preparation Instructions
Add 2 ml from bag 3
Add 1.67 ml from bag 4
Add 1.67 ml from bag 5
Add 0.2 ml from bag 6
Add 0.15 ml from bag 12
Add 0.313 ml of stock solution to minibag
Add 0.625 ml of stock solution to minibag
Add 1.25 ml of stock solution to minibag
Add 2.5 ml of stock solution to minibag
Remove 15 ml of NS from minibag (5 ml for
amount being added and 10 ml overfill). Add
5 ml of stock solution to minibag.
Remove 20 ml of NS from minibag (10 ml
for amount being added and 10 ml overfill).
Add 10 ml of stock solution to minibag
Remove 30 ml from of NS from minibag (20
ml for amount being added and 10 ml
overfill). Add 20 ml of stock solution to
minibag.
Final
Concentration
(mg/ml)
0.00008
0.0004
0.002
0.012
0.06
0.3
0.625
1.25
2.5
5
10
20
This is a confidential professional/peer review and quality assessment document of Marquette General Health System of Marquette, MI. It is protected from disclosure pursuant to the
provisions of MCL 333.20175, MCL 333.21513, MCL 21515, MCL 331.531, MCL 331.533, MCL 330.1143a, and other state and federal laws. Unauthorized disclosure or duplication is
absolutely prohibited.